What do systematic reviews say?

Dopamine agonist plus co‐intervention vs co‐intervention

It is very uncertain whether dopamine agonist plus co‐intervention changes any other adverse events compared with co‐intervention (very low certainty).

• Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
  OR 3.03 [0.12, 75.28]
  2 studies · 366 participants
  Very low

Early intervention (mobilization or active exercise) vs usual care

• Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit 2018 · Cochrane Headline outcomes only
  no estimate extracted
  4 studies · 690 participants
  Low

Dopamine agonist vs other active intervention

• Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 170 participants
  GRADE not reported

Dopamine agonist vs placebo or no intervention

It is very uncertain whether dopamine agonist changes any other adverse events compared with placebo/no intervention (very low certainty).

• Dopamine agonists for preventing ovarian hyperstimulation syndrome 2021 · Cochrane Headline outcomes only
  OR 4.54 [1.49, 13.84]
  2 studies · 264 participants
  Very low

Insulin analogues vs biphasic insulin

It is very uncertain whether insulin analogues changes any adverse events other than hypoglycaemia compared with biphasic insulin (very low certainty).

• Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes only
  RR 0.83 [0.44, 1.56]
  2 studies · 500 participants
  Very low